FDA labels for Mounjaro and Zepbound say about 20% less contraceptive hormone was absorbed after a single dose. Reproductive endocrinologists explain what that means for birth control.
Recap by typeshit. Full story at Yahoo Health.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A general rundown naming semaglutide, liraglutide and tirzepatide brands alongside promotional benefit claims. Evergreen material with nothing new in it.
The bank expects stronger tablet sales. It also points to lower margins and slower earnings growth for Novo Nordisk over the long run.
Loading…